FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2328543694> ?p ?o ?g. }

• W2328543694 endingPage "9597" @default.
• W2328543694 startingPage "9578" @default.
• W2328543694 abstract "Combination of dopamine D3 antagonism, serotonin 5-HT1A partial agonism, and antagonism at 5-HT2A leads to a novel approach to potent atypical antipsychotics. Exploitation of the original structure–activity relationships resulted in the identification of safe and effective antipsychotics devoid of extrapyramidal symptoms liability, sedation, and catalepsy. The potential atypical antipsychotic 5bb was selected for further pharmacological investigation. The distribution of c-fos positive cells in the ventral striatum confirmed the atypical antipsychotic profile of 5bb in agreement with behavioral rodent studies. 5bb administered orally demonstrated a biphasic effect on the MK801-induced hyperactivity at dose levels not able to induce sedation, catalepsy, or learning impairment in passive avoidance. In microdialysis studies, 5bb increased the dopamine efflux in the medial prefrontal cortex. Thus, 5bb represents a valuable lead for the development of atypical antipsychotics endowed with a unique pharmacological profile for addressing negative symptoms and cognitive deficits in schizophrenia." @default.
• W2328543694 created "2016-06-24" @default.
• W2328543694 creator A5004031244 @default.
• W2328543694 creator A5004950855 @default.
• W2328543694 creator A5008299305 @default.
• W2328543694 creator A5013981616 @default.
• W2328543694 creator A5015069863 @default.
• W2328543694 creator A5020722865 @default.
• W2328543694 creator A5021791097 @default.
• W2328543694 creator A5026230840 @default.
• W2328543694 creator A5040940946 @default.
• W2328543694 creator A5057114106 @default.
• W2328543694 creator A5060371306 @default.
• W2328543694 creator A5064257636 @default.
• W2328543694 creator A5066252280 @default.
• W2328543694 creator A5066660822 @default.
• W2328543694 creator A5068196173 @default.
• W2328543694 creator A5072264240 @default.
• W2328543694 creator A5074743737 @default.
• W2328543694 creator A5079124576 @default.
• W2328543694 date "2014-11-07" @default.
• W2328543694 modified "2023-10-18" @default.
• W2328543694 title "Targeting Dopamine D₃ and Serotonin 5-HT_1A and 5-HT_2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies" @default.
• W2328543694 cites W136211312 @default.
• W2328543694 cites W1895992443 @default.
• W2328543694 cites W1964176367 @default.
• W2328543694 cites W1969325908 @default.
• W2328543694 cites W1979759377 @default.
• W2328543694 cites W1980622706 @default.
• W2328543694 cites W1987152895 @default.
• W2328543694 cites W1989893437 @default.
• W2328543694 cites W1990186442 @default.
• W2328543694 cites W1995249085 @default.
• W2328543694 cites W1999454787 @default.
• W2328543694 cites W1999918649 @default.
• W2328543694 cites W2000890192 @default.
• W2328543694 cites W2003712515 @default.
• W2328543694 cites W2012930217 @default.
• W2328543694 cites W2013392365 @default.
• W2328543694 cites W2016723993 @default.
• W2328543694 cites W2021569168 @default.
• W2328543694 cites W2026005761 @default.
• W2328543694 cites W2044428276 @default.
• W2328543694 cites W2046315930 @default.
• W2328543694 cites W2051030373 @default.
• W2328543694 cites W2055595962 @default.
• W2328543694 cites W2062610641 @default.
• W2328543694 cites W2070357412 @default.
• W2328543694 cites W2070639484 @default.
• W2328543694 cites W2074914062 @default.
• W2328543694 cites W2075557883 @default.
• W2328543694 cites W2076831847 @default.
• W2328543694 cites W2081573540 @default.
• W2328543694 cites W2084253999 @default.
• W2328543694 cites W2089188189 @default.
• W2328543694 cites W2089420913 @default.
• W2328543694 cites W2090979638 @default.
• W2328543694 cites W2092216786 @default.
• W2328543694 cites W2119971225 @default.
• W2328543694 cites W2121845894 @default.
• W2328543694 cites W2129863852 @default.
• W2328543694 cites W2136472480 @default.
• W2328543694 cites W2151331628 @default.
• W2328543694 cites W2152770536 @default.
• W2328543694 cites W2158137297 @default.
• W2328543694 cites W2159155203 @default.
• W2328543694 cites W2162857263 @default.
• W2328543694 cites W2171956687 @default.
• W2328543694 cites W2947491179 @default.
• W2328543694 cites W4211063728 @default.
• W2328543694 doi "https://doi.org/10.1021/jm501119j" @default.
• W2328543694 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25343529" @default.
• W2328543694 hasPublicationYear "2014" @default.
• W2328543694 type Work @default.
• W2328543694 sameAs 2328543694 @default.
• W2328543694 citedByCount "44" @default.
• W2328543694 countsByYear W23285436942014 @default.
• W2328543694 countsByYear W23285436942015 @default.
• W2328543694 countsByYear W23285436942016 @default.
• W2328543694 countsByYear W23285436942017 @default.
• W2328543694 countsByYear W23285436942018 @default.
• W2328543694 countsByYear W23285436942019 @default.
• W2328543694 countsByYear W23285436942020 @default.
• W2328543694 countsByYear W23285436942021 @default.
• W2328543694 countsByYear W23285436942022 @default.
• W2328543694 countsByYear W23285436942023 @default.
• W2328543694 crossrefType "journal-article" @default.
• W2328543694 hasAuthorship W2328543694A5004031244 @default.
• W2328543694 hasAuthorship W2328543694A5004950855 @default.
• W2328543694 hasAuthorship W2328543694A5008299305 @default.
• W2328543694 hasAuthorship W2328543694A5013981616 @default.
• W2328543694 hasAuthorship W2328543694A5015069863 @default.
• W2328543694 hasAuthorship W2328543694A5020722865 @default.
• W2328543694 hasAuthorship W2328543694A5021791097 @default.
• W2328543694 hasAuthorship W2328543694A5026230840 @default.
• W2328543694 hasAuthorship W2328543694A5040940946 @default.
• W2328543694 hasAuthorship W2328543694A5057114106 @default.
• W2328543694 hasAuthorship W2328543694A5060371306 @default.

• next